OptiNose, Inc. financial data

Symbol
OPTN on Nasdaq
Industry
Pharmaceutical Preparations
Location
777 Township Line Road, Suite 300, Yardley, PA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 102 % +53.3%
Quick Ratio 9.32 % +78.3%
Debt-to-equity -239 % +12.3%
Return On Equity 150 % -59.2%
Return On Assets -38.5 % +2.16%
Operating Margin -25.1 % +51.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 151M shares +34.4%
Common Stock, Shares, Outstanding 150M shares +33.5%
Entity Public Float 119M USD -40.9%
Common Stock, Value, Issued 150K USD +33.9%
Weighted Average Number of Shares Outstanding, Basic 147M shares +31.7%
Weighted Average Number of Shares Outstanding, Diluted 151M shares +34.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 75.1M USD +3.91%
Research and Development Expense 4.7M USD -47.3%
Costs and Expenses 93.9M USD -14.6%
Operating Income (Loss) -18.8M USD +50%
Net Income (Loss) Attributable to Parent -40.9M USD +11.7%
Earnings Per Share, Basic -0.34 USD/shares +29.2%
Earnings Per Share, Diluted -0.36 USD/shares +25%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 20.8M USD -5.92%
Inventory, Net 11.4M USD +47.5%
Other Assets, Current 2.87M USD +11%
Assets, Current 129M USD +24.4%
Property, Plant and Equipment, Net 714K USD -1.25%
Operating Lease, Right-of-Use Asset 1.47M USD -39.8%
Other Assets, Noncurrent 2.23M USD +28.4%
Assets 132M USD +24.3%
Accounts Payable, Current 1.73M USD -73.3%
Employee-related Liabilities, Current 82K USD -1.21%
Accrued Liabilities, Current 30.1M USD +11.4%
Liabilities, Current 32.7M USD -80.1%
Operating Lease, Liability, Noncurrent 611K USD -2.24%
Other Liabilities, Noncurrent 1.33M USD +305%
Liabilities 175M USD -0.57%
Accumulated Other Comprehensive Income (Loss), Net of Tax -84K USD 0%
Retained Earnings (Accumulated Deficit) -742M USD -5.84%
Stockholders' Equity Attributable to Parent -42.9M USD +38.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -73.4M USD -42.6%
Liabilities and Equity 132M USD +24.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -22M USD -110%
Net Cash Provided by (Used in) Financing Activities 162K USD -34.9%
Net Cash Provided by (Used in) Investing Activities -22K USD
Common Stock, Shares Authorized 350M shares +6900%
Common Stock, Shares, Issued 150M shares +33.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -22M USD -114%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 91.4M USD +28.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 9.22M USD +117%
Deferred Tax Assets, Valuation Allowance 118M USD +2.2%
Deferred Tax Assets, Gross 119M USD +1.96%
Operating Lease, Liability 1.52M USD -41.4%
Depreciation 422K USD +0.72%
Payments to Acquire Property, Plant, and Equipment 22K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -40.9M USD +11.7%
Lessee, Operating Lease, Liability, to be Paid 1.69M USD -39.1%
Property, Plant and Equipment, Gross 5.73M USD +5.7%
Operating Lease, Liability, Current 865K USD -38.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 436K USD -20.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.05M USD -51.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +19.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 172K USD -8.02%
Lessee, Operating Lease, Liability, to be Paid, Year Three 205K USD +150%
Deferred Tax Assets, Operating Loss Carryforwards 88.2M USD +5.75%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares
Depreciation, Depletion and Amortization 83K USD +15.3%
Share-based Payment Arrangement, Expense 6.37M USD -1.41%
Interest Expense 19.8M USD +13.7%